SEARCH

SEARCH BY CITATION

References

  • 1
    Palmgren M.G., Axelsen K.B. (1998) Evolution of P-Type ATPases. Biochim Biophys Acta;13:65376545.
  • 2
    Palmgren M.G., Axelsen K.B. (1998) Evolution of substrate specificities in the P-Type ATPase superfamily. J Mol Evol;46:84101.
  • 3
    Paulusma C.C., Elferink R.P.J.O. (2005) The type 4 subfamily of P-type ATPases, putative aminophospholipid translocases with a role in human disease. Biochim Biophys Acta;1741:1124.
  • 4
    Mansharamani M., Chilton B.S. (2001) Erratum to “The reproductive importance of P-type ATPases”. Mol Cell Endocrinol;183:123126.
  • 5
    Toyoshima C., Nomura H., Tsuda T. (2004) Lumenal gating mechanism revealed in calcium pump crystal structures with phosphate analogues. Nature;432:361368.
  • 6
    Obara K., Miyashita N., Xu C., Toyoshima I., Sugita Y., Inesi G., Toyoshima C. (2005) Structural role of countertransport revealed in Ca2+ pump crystal structure in the absence of Ca2+. Proc Natl Acad Sci USA;102:1448914496.
  • 7
    Inesi G., Lewis D., Ma H., Prasad A., Toyoshima C. (2006) Concerted conformational effects of Ca2+ and ATP are required for activation of sequential reactions in the Ca2+ ATPase (SERCA) catalytic cycle. Biochemistry;45:1376913778.
  • 8
    Bublitz M., Morth J.P., Nissen P. (2011) P-type ATPases at a glance. J Cell Sci;124:25152519.
  • 9
    Toyoshima C., Yonekura S., Tsueda J., Iwasawa S. (2011) Trinitrophenyl derivatives bind differently from parent adenine nucleotides to Ca2+-ATPase in the absence of Ca2+. Proc Natl Acad Sci USA;108:18331838.
  • 10
    Yatime L., Laursen M., Morth J.P., Esmann M., Nissen P., Fedosova N.U. (2011) Structural insights into the high affinity binding of cardiotonic steroids to the Na+,K+-ATPase. J Struct Biol;174:296306.
  • 11
    Abe K., Tani K., Fujiyoshi Y. (2011) Conformational rearrangement of gastric H(+),K(+)-ATPase induced by an acid suppressant. Nat Commun;2:155161.
  • 12
    Ogawa H., Toyoshima C. (2002) Homology modeling of the cation binding sites of Na+K+-ATPase. Proc Natl Acad Sci USA;99:1597715982.
  • 13
    Reddy Ch.S., Vijayasarathya K., Srinivasa E., Sastry G.M., Sastry G.N. (2006) Homology modeling of membrane proteins: a critical assessment. Comp Biol Chem;30:120126.
  • 14
    Bindu P.H., Sastry G.M., Murty U.S., Sastry G.N. (2004) Structural and conformational changes concomitant with the E1-E2 transition in H+ K+-ATPase: a comparative protein modeling study. Biochem Biophys Res Commun;319:312320.
  • 15
    Clausen J.D., Andersen J.P. (2004) Functional consequences of alterations to Thr247, Pro248, Glu340, Asp813, Arg819, and Arg822 at the interfaces between domain P, M3, and L6-7 of sarcoplasmic reticulum Ca2+-ATPase: roles in Ca2+ interaction and phosphoenzyme processing. J Biol Chem;279:5442654437.
  • 16
    Marchand A., Winther A.-M.L., Holm P.J., Olesen C., Montigny C., Arnou B., Champeil P., Clausen J.D., Vilsen B., Andersen J.P., Nissen P., Jaxel C., Moller J.V., le Maire M. (2008) Crystal structure of D351A and P312A mutant forms of the mammalian sarcoplasmic reticulum Ca2+-ATPase reveals key events in phosphorylation and Ca2+ release. J Biol Chem;283:1486714882.
  • 17
    Inesi G., Ma H., Lewis D., Xu C. (2004) Ca2+ occlusion and gating function of Glu309 in the ADP-fluoroaluminate analog of the Ca22+-ATPase phosphoenzyme intermediate. J Biol Chem;279:3162931637.
  • 18
    Karjalainen L., E-Hauserb K., Barth A. (2007) Proton paths in the sarcoplasmic reticulum Ca2+-ATPase. Biochim Biophys Acta;1767:13101318.
  • 19
    Sorensen T.L.-M., Clausen J.D., Jensen A.M., Vilsen B., Moller J.V., Andersen J.P., Nissen P. (2004) Localization of a K+-binding site involved in dephosphorylation of the sarcoplasmic reticulum Ca2+-ATPase. J Biol Chem;279:4635546358.
  • 20
    Morth J.P., Pedersen B.P., Toustrup-Jensen M.S., Sorensen T.L.-M., Petersen J., Andersen J.P., Vilsen B., Nissen P. (2007) Crystal structure of the sodium–potassium pump. Nature;450:10431049.
  • 21
    Shinoda T., Ogawa H., Cornelius F., Toyoshima C. (2009) Crystal structure of the sodium-potassium pump at 2.4 Å resolution. Nature;459:446451.
  • 22
    Ogawa H., Shinoda T., Cornelius F., Toyoshima C. (2009) Crystal structure of the sodium-potassium pump (Na+,K+-ATPase) with bound potassium and ouabain. Proc Natl Acad Sci USA;106:1374213747.
  • 23
    Munson K., Law R.J., Sachs G. (2007) Analysis of the gastric H,K ATPase for ion pathways and inhibitor binding sites. Biochemistry;46:53985417.
  • 24
    Koenderink J.B., Swarts H.G., Willems P.H., Krieger E., De Pont J.J. (2004) A conformation-specific interhelical salt bridge in the K+ binding site of gastric H,K-ATPase. J Biol Chem;279:1641716424.
  • 25
    Chourasia M., Sastry G.M., Sastry G.N. (2005) Proton binding sites and conformational analysis of H+K+-ATPase. Biochem Biophys Res Commun;336:961966.
  • 26
    Asano S., Io T., Kimura T., Sakamoto S., Takeguchi N. (2001) Alanine-scanning mutagenesis of the sixth transmembrane segment of gastric H+,K+-ATPase α-subunit. J Biol Chem;276:3126531273.
  • 27
    Laursen M., Bublitz M., Moncoq K., Olesen C., Moller J.V., Young H.S., Nissen P., Morth J.P. (2009) Cyclopiazonic acid is complexed to a divalent metal ion when bound to the sarcoplasmic reticulum Ca2+-ATPase. J Biol Chem;284:1351313518.
  • 28
    Domene C., Vemparala S., Klein M.L., Venien-Bryan C., Doyle D.A. (2006) Role of aromatic localization in the gating process of a potassium channel. Biophys J;90:L01L03.
  • 29
    Moiler J.V., Juul B., le Maire M. (1996) Structural organization, ion transport, and energy transduction of P-type ATPases. Biochim Biophys Acta;1286:151.
  • 30
    Mueller B., Zhao M., Negrashov I.V., Bennett R., Thomas D.D. (2004) SERCA structural dynamics induced by ATP and calcium. Biochemistry;43:1284612854.
  • 31
    Bilmen J.G., Wootton L.L., Michelangeli F. (2002) The mechanism of inhibition of the sarco/endoplasmic reticulum Ca2+ ATPase by paxilline. Arch Biochem Biophys;406:5564.
  • 32
    Ma H., Lewis D., Xu C., Inesi G., Toyoshima C. (2005) Functional and structural roles of critical amino acids within the “N”, “P”, and “A” domains of the Ca2+ ATPase (SERCA) headpiece. Biochemistry;44:80908100.
  • 33
    Fedosova N.U., Champeil P., Esmann M. (2002) Nucleotide binding to Na,K-ATPase: the role of electrostatic interactions. Biochemistry;41:12671273.
  • 34
    Ohizumi Y., Sasakia S., Kusumib T., Ohtanic I.I. (1996) Ptilomycalin A, a novel Na+,K+- or Ca2+-ATPase inhibitor, competitively interacts with ATP at its binding site. Eur J Pharm;310:9598.
  • 35
    Breier A., Bohacova V., Docolomansky P. (2006) Inhibition of (Na+/K+)-ATPase by Cibacron Blue 3G-A and its analogues. Gen Physiol Biophys;25:439453.
  • 36
    Kubala M., Teisinger J., Ettrich R., Hofbauerova K., Kopecky V. Jr, Baumruk V., Krumscheid R., Plasek J., Schoner W., Amler E. (2003) Eight amino acids form the ATP recognition site of Na+/K+-ATPase. Biochemistry;42:64466452.
  • 37
    Gatto C., Thornewell S.J., Holden J.P., Kaplan J.H. (1999) Cys577 is a conformationally mobile residue in the ATP-binding domain of the Na,K-ATPase α-subunit. J Biol Chem;35:2499525003.
  • 38
    Fedosova N.U., Esmann M. (2007) Nucleotide binding to Na,K-ATPase: pK values of the groups affecting the high affinity site. Biochemistry;46:91169122.
  • 39
    Clarke R.J., Apell H.-J., Kong B.Y. (2007) Allosteric effect of ATP on Na+,K+-ATPase conformational kinetics. Biochemistry;46:70347044.
  • 40
    Reenstra W.W., Crothers J. Jr, Forte J.G. (2007) The conformation of H,K-ATPase determines the nucleoside triphosphate (NTP) selectivity for active proton transport. Biochemistry;46:1014510152.
  • 41
    Yatime L., Buch-Pedersen M.J., Musgaard M., Morth J.P., Winther A.-M.L., Pedersen B.P., Olesen C., Andersen J.P., Vilsen B., Schiøtt B., Palmgren M.G., Møller J.V., Nissen P., Fedosova N. (2009) P-type ATPases as drug targets: tools for medicine and science. Biochim Biophys Acta;1787:207220.
  • 42
    Reddy A.S., Pati S.P., Kumar P.P., Pradeep H.N., Sastry G.N. (2007) Virtual screening in drug discovery – a computational perspective. Curr Protein Pept Sci;8:329351.
  • 43
    Roufogalis B.D., Qian L.I., Tran V.H., Kable E.P.W., Duke C.C. (1999) Investigation of plant-derived phenolic compounds as plasma membrane Ca2+-ATPase inhibitors with potential cardiovascular activity. Drug Dev Res;46:235249.
  • 44
    Abe K., Tani K., Nishizawa T., Fujiyoshi Y. (2009) Inter-subunit interaction of gastric H+,K+-ATPase prevents reverse reaction of the transport cycle. EMBO J;28:16371643.
  • 45
    Sohoel H., Jensen A.M., Moller J.V., Nissen P., Denmeade S.R., Isaacs J.T., Olsen C.E., Christensen S.B. (2006) Natural products as starting material for development of second-generation SERCA inhibitors targeted towards prostate cancer cells. Bioorg Med Chem;14:28102815.
  • 46
    Thastrup O., Cullen P.J., Drobak B.K., Hanley M.R., Dawson A.P. (1990) Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2+-ATPase. Proc Natl Acad Sci USA;87: 24662470.
  • 47
    Verboomen H., Wuytack F., De Smedt H., Himpens B., Casteels R. (1992) Functional difference between SERCA2a and SERCA2b Ca2+ pumps and their modulation by phospholamban. Biochem J;286:591596.
  • 48
    Paula S., Tabet M.R., Ball W.J. Jr (2005) Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition. Biochemistry;44:498510.
  • 49
    Yudowski G.A., Shimon M.B., Tal D.M., Gonzalez-Lebrero R.M., Rossi R.C., Garrahan P.J., Beauge L.A., Karlish S.J.D. (2003) Evidence for tryptophan residues in the cation transport path of the Na+,K+-ATPase. Biochemistry;42:1021210222.
  • 50
    Stimac R., Kerek F., Apell H.-J. (2005) Mechanism of the Na+,K+-ATPase inhibition by MCS derivatives. J Membr Biol;205:89101.
  • 51
    Pocas E.S.C., Costa P.R., da Silva A.J., Noel F. (2003) 2-Methoxy-3,8,9-trihydroxy coumestan: a new synthetic inhibitor of Na+,K+-ATPase with an original mechanism of action. Biochem Pharmacol;66:21692176.
  • 52
    Guennoun-Lehmann S., Fonseca J.E., Horisberger J.-D., Rakowski R.F. (2007) Palytoxin acts on Na+,K+-ATPase but not non-gastric H+,K+-ATPase. J Membr Biol;216:107116.
  • 53
    Jain K.S., Shahb A.K., Bariwalb J., Shelkea S.M., Kalec A.P., Jagtapc J.R., Bhosalec A.V. (2007) Recent advances in proton pump inhibitors and management of acid-peptic disorder. Bioorg Med Chem;15:11811205.
  • 54
    Kim C.G., Watts J.A., Watts A. (2005) Ligand docking in the Gastric H+/K+-ATPase: homology modeling of reversible inhibitor binding sites. J Med Chem;48:71457152.
  • 55
    Vagin O., Denevich S., Munson K., Sachs G. (2002) SCH28080, a K+-competitive inhibitor of the gastric H,K-ATPase, binds near the M5-6 luminal loop, preventing K+ access to the ion binding domain. Biochemistry;41:1275512762.
  • 56
    Satoh K., Nagai F., Kano I. (2000) Inhibition of H+,K+-ATPase by hinesol, a major component of So-jutsu, by interaction with enzyme in the E1 state. Biochem Pharmacol;59:881886.
  • 57
    Shin J.M., Cho Y.M., Sachs G. (2004) Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors. J Am Chem Soc;126:78007811.
  • 58
    Shin J.M., Sachs G. (2004) Corrigendum to “Differences in binding properties of two proton pump inhibitors on the gastric H+, K+-ATPase in vivo”. Biochem Pharmacol;68:21172127.
  • 59
    Vanderhoff B.T., Tahboub R.M. (2002) Proton pump inhibitors: an update. Clin Pharmacol;66:273280.
  • 60
    Jia H.Y., Lee H.W., Kim H.H., Choi J.K., Lee H.S. (2005) Characterization of human liver cytochrome P450 enzymes involved in the metabolism of a new H+/K+-ATPase inhibitor KR-60436. Toxicol Lett;155:103114.